Loading rounds…
Loading rounds…
Explore funding rounds, the companies behind them and the investors taking part.
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| C CleafyCompany profile Provides cybersecurity platform for banks to detect and prevent financial fraud and cyberattacks Provides cybersecurity platform for banks to detect and prevent financial fraud and cyberattacks | €12M | Series B | Fintech | Italy | Investors | |
| AL Builds open infrastructure for programmable finance on Bitcoin | $5.2M | Seed | Fintech | Switzerland |
Ranked by rounds participated in · All time
Metriport, Arintra, Multiplier
Transfyr, General Intuition, Castelion
Rillet, Castelion, Hadrian
SiFly Aviation, Apollo Atomics, Hopscotch Primary Care
Higgsfield, Lovable, Cambridge Aerospace
Explore published rounds while the next edition is being prepared.
| MS Develops orbital power infrastructure for satellites | >$10M | Seed | Space tech | United States | Investors |
| D Provides analytics and trading tools for decentralized exchanges | $3M | Seed | Fintech | Spain | Investors |
| Q An open-source vector search engine. | $50M | Series B | AI | Germany | Investors |
| X Develops endovascular surgical robots for neurovascular care | $30M | Series CSeries C+ | Healthtech | United States | Investors |
| Q Provides autonomous digital workforces for complex back-office operations | $15M | Series A | AI | United States | Investors |
| B AI-native operating system for supply chain operations | $26M | Series A | Logistics | United States | Investors |
| G GumloopCompany profile Provides AI-powered automation tools for non-technical employees to build and deploy autonomous agents Provides AI-powered automation tools for non-technical employees to build and deploy autonomous agents | $50M | Series B | AI | United States | Investors |
| CM Combat MedicalCompany profile Develops hyperthermic intravesical chemotherapy treatment for BCG unresponsive bladder cancer Develops hyperthermic intravesical chemotherapy treatment for BCG unresponsive bladder cancer | £2.6M | Series A | Healthtech | United Kingdom | Investors |